Binge-eating Disorder Treatment Market by Distribution Channel, Type and Geography- Forecast and Analysis 2023-2027
| Published: May 2023 | Pages: 156 | SKU: IRTNTR75448 |
Binge-eating Disorder Treatment Market Analysis Report 2023-2027:
The binge-eating disorder treatment market size is estimated to grow at a CAGR of 7.26% between 2022 and 2027. The market size is forecast to increase by USD 578.04 million. The growth of the market depends on several factors, including the increasing prevalence of binge-eating disorders, the growing obese population, and the rising government initiatives.
This binge-eating disorder treatment market report extensively covers market segmentation by distribution channel (offline and online), type (antidepressants, anticonvulsants, and stimulants and others), and geography (North America, Europe, Asia, and Rest of World (ROW)). It also includes an in-depth analysis of drivers, trends, and challenges. Furthermore, the report includes historic market data from 2017 to 2021.
What will be the Size of the Binge-eating Disorder Treatment Market During the Forecast Period?
To learn more about this report, View Report Sample
Binge-eating Disorder Treatment Market: Key Drivers, Trends, Challenges, and Customer Landscape
Increasing prevalence of binge-eating disorder is notably driving the market growth, although factors such as side effects of binge-eating disorder drugs impede the market growth. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
Key Binge-eating Disorder Treatment Market Driver
One of the key factors driving the binge-eating disorder treatment market growth is the increasing prevalence of binge-eating disorder. As binge-eating disorders is prevalent across all age groups, races, and income levels, it can significantly contribute to the binge-eating disorder treatment market growth. For instance, in the US, this condition has a lifetime frequency of 2.6%. 49% of people with binge-eating disorders have a lifetime history of two or more comorbid disorders; around 79% of people with binge-eating disorders have one psychiatric disorder.
As the patients have to face a lot of impairments in their lifestyle that are treated by the medications available in the market, It is fuelling the revenue growth of the global binge-eating disorder treatment market. Furthermore, the symptomatic treatment by antidepressants is helping in preventing various patients from complications of binge-eating disorder. Hence, such factors can significantly drive the global binge-eating disorder treatment market during the forecast period.
Significant Binge-eating Disorder Treatment Market Trends
A key factor shaping the binge-eating disorder treatment market growth is the development and approval of new drugs. Pharmaceutical vendors are significantly developing new binge-eating disorder treatments for approval as there is an increasing prevalence of binge-eating disorders. For instance, in 2022, Tonix Pharmaceuticals Holding Corp. and Massachusetts General Hospital announced an agreement to assess TNX-1900 as a probable treatment for patients with binge-eating disorders.
Furthermore, in January 2023, Tryp Therapeutics announced interim results of its Phase II trial with psilocybin (TRP-8803) for the treatment of binge-eating disorder, with daily binge-eating episodes reduced by an average of 80%. Thus the development and approval of new drugs continues to drive the global binge-eating disorder treatment market during the forecast period.
Major Binge-eating Disorder Treatment Market Challenge
Side effects of binge-eating disorder drugs are the key challenges hindering the binge-eating disorder treatment market growth. Factors such as the use of binge-eating disorder drugs during pregnancy may lead to congenital abnormalities and stillbirths, and binge-eating disorder drugs cause spontaneous abortion, persistent pulmonary hypertension in newborns, low birth weight, gestational hypertension, prematurity, postpartum hemorrhage, and delayed motor development in the newborn can significantly decrease the adoption of binge-eating disorder treatment.
Furthermore,binge-eating disorder drugs produce physical side effects such as headaches, insomnia/hypersomnia, and gastric distress, as well as emotional side effects including hyperactivity, hostility, emotional lability, irritability, and self-harm. Thus, these side effects can impede the global binge-eating disorder treatment market during the forecast period.
Key Binge-eating Disorder Treatment Market Customer Landscape
The market report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.
Global Binge-eating Disorder Treatment Market Customer Landscape
Who are the Major Binge-eating Disorder Treatment Market Vendors?
Vendors are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.
Alvogen Iceland ehf - The company offers a binge-eating disorder treatment drug called Forfivo XL tablets under its subsidiary called Almatica.
The research report also includes detailed analyses of the competitive landscape of the market and information about 15 market vendors, including:
- Alvogen Iceland ehf
- Bausch Health Co. Inc.
- Chronos Therapeutics Ltd.
- Currax Pharmaceuticals LLC
- Eli Lilly and Co.
- Johnson and Johnson Services Inc.
- Lupin Ltd.
- Omeros Corp.
- Pyramid Healthcare Inc.
- Rosewood Centers for Eating disorders
- Sumitomo Pharma Co. Ltd.
- Takeda Pharmaceutical Co. Ltd.
- Timberline Knolls Residential Treatment Center
- Tonix Pharmaceuticals Holding Corp.
- Tryp Therapeutics Inc.
- Viatris Inc.
- VIVUS LLC
- Walden Behavioral Care
Qualitative and quantitative analysis of vendors has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize vendors as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize vendors as dominant, leading, strong, tentative, and weak.
What is the Fastest-Growing Segment in the Binge-eating Disorder Treatment Market?
The market share growth by the offline segment will be significant during the forecast period. The offline sector dominated the global binge-eating disorder treatment market and held the largest share in 2022. As offline stores offer product assurance, authenticity, and verification, most customers prefer buying through offline distribution channels.
Get a glance at the market contribution of various segments View the PDF Sample
The offline segement was valued at USD 781.65 million in 2017 and continued to grow until 2021. The offline store has several advantages based on factors such as geographical presence, ease of production and inventory management, and goods transportation. Market players significantly invest in brick-and-mortar organized retail stores to increase their regional and global shares in the market. Due to the increased footfall in offline stores, vendors are investing in brick-and-mortar stores to sell binge-eating disorder treatment drugs. Thus, it is anticipated that a rise in the retail sector, which improves access to items, will accelerate offline segment growth, which, in turn, will boost the growth of the global binge-eating disorder treatment market during the forecast period.
Which are the Key Regions for the Binge-eating Disorder Treatment Market?
For more insights on the market share of various regions Download PDF Sample now!
North America is estimated to contribute 38% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period. The growth of the regional market can be attributed to factors such as the high prevalence of binge-eating disorders and the availability of several treatments. There is an increasing prevalence of binge-eating disorders in the US, which offers opportunities for growth in the market in North America.
Also, according to The World Bank Group (WBG), in 2020, healthcare expenditure in the US increased by 9.7% and reached USD 4.1 trillion or USD 12,530 per person. Furthermore, the country's healthcare expenditure accounted for 19.7% of its gross domestic product (GDP) in 2020. Hence, such factors drive regional market growth during the forecast period.
In 2020, the outbreak of COVID-19 negatively impacted the growth of the binge-eating disorder treatment market in North America. However, in the second half of 2020, several rehabilitation centers across this region started providing counseling sessions and treatments through digital channels, which enabled the market to deal with the pandemic's negative effects by registering growth through online channels. Furthermore, in 2021, the initiation of large-scale vaccination drives led to the lifting of lockdown restrictions and the restoration of operations in healthcare units. As a result, larger inflows of patients at the rehabilitation facilities for treatment were observed in North America as compared to 2020. Such factors are expected to drive the growth of the market in North America during the forecast period.
Segment Overview
The binge-eating disorder treatment market report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2017 to 2027.
- Distribution Channel Outlook (USD Million, 2017 - 2027)
- Offline
- Online
- Type Outlook (USD Million, 2017 - 2027)
- Antidepressants
- Anticonvulsants
- Stimulants and others
- Region Outlook (USD Million, 2017 - 2027)
- North America
- The U.S.
- Canada
- Europe
- The U.K.
- Germany
- France
- Rest of Europe
- Asia
- China
- India
- Rest of the World
- South Africa
- Rest of the Middle East & Africa
- North America
Parent Market Analysis
Technavio categorizes the global binge-eating disorder treatment market as a part of the pharmaceutical market within the overall healthcare industry. The parent pharmaceuticals market covers products and companies engaged in R&D or the production of generic drugs, non-generic drugs, and veterinary drugs. Our market research report has extensively covered external factors influencing the parent market growth during the forecast period.
|
Binge-eating Disorder Treatment Market Scope |
|
|
Report Coverage |
Details |
|
Page number |
156 |
|
Base year |
2022 |
|
Historic period |
2017-2021 |
|
Forecast period |
2023-2027 |
|
Growth momentum & CAGR |
Accelerate at a CAGR of 7.26% |
|
Market growth 2023-2027 |
USD 578.04 million |
|
Market structure |
Concentrated |
|
YoY growth 2022-2023(%) |
6.24 |
|
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
|
Performing market contribution |
North America at 38% |
|
Key countries |
US, UK, Germany, China, and India |
|
Competitive landscape |
Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks |
|
Key companies profiled |
Alvogen Iceland ehf, Bausch Health Co. Inc., Chronos Therapeutics Ltd., Currax Pharmaceuticals LLC, Eli Lilly and Co., Johnson and Johnson Services Inc., Lupin Ltd., Omeros Corp., Pyramid Healthcare Inc., Rosewood Centers for Eating disorders, Sumitomo Pharma Co. Ltd., Takeda Pharmaceutical Co. Ltd., Timberline Knolls Residential Treatment Center, Tonix Pharmaceuticals Holding Corp., Tryp Therapeutics Inc., Viatris Inc., VIVUS LLC, and Walden Behavioral Care |
|
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period. |
|
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
What are the Key Data Covered in this Binge-eating Disorder Treatment Market Research Report?
- CAGR of the market during the forecast period
- Detailed information on factors that will drive the growth of the market between 2023 and 2027
- Precise estimation of the market size and its contribution to the market with a focus on the parent market
- Accurate predictions about upcoming trends and changes in consumer behaviour
- Growth of the market across North America, Europe, Asia, and Rest of World (ROW)
- Thorough analysis of the market’s competitive landscape and detailed information about vendors
- Comprehensive analysis of factors that will challenge the growth of market vendors
We can help! Our analysts can customize this market research report to meet your requirements.
1 Executive Summary
- 1.1 Market overview
- Exhibit 01: Executive Summary – Chart on Market Overview
- Exhibit 02: Executive Summary – Data Table on Market Overview
- Exhibit 03: Executive Summary – Chart on Global Market Characteristics
- Exhibit 04: Executive Summary – Chart on Market by Geography
- Exhibit 05: Executive Summary – Chart on Market Segmentation by Distribution Channel
- Exhibit 06: Executive Summary – Chart on Market Segmentation by Type
- Exhibit 07: Executive Summary – Chart on Incremental Growth
- Exhibit 08: Executive Summary – Data Table on Incremental Growth
- Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
2 Market Landscape
- 2.1 Market ecosystem
- Exhibit 10: Parent market
- Exhibit 11: Market Characteristics
3 Market Sizing
- 3.1 Market definition
- Exhibit 12: Offerings of vendors included in the market definition
- 3.2 Market segment analysis
- Exhibit 13: Market segments
- 3.3 Market size 2022
- 3.4 Market outlook: Forecast for 2022-2027
- Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
- Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
- Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
- Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
4 Historic Market Size
- 4.1 Global binge-eating disorder treatment market 2017 - 2021
- Exhibit 18: Historic Market Size – Data Table on global binge-eating disorder treatment market 2017 - 2021 ($ million)
- 4.2 Distribution Channel Segment Analysis 2017 - 2021
- Exhibit 19: Historic Market Size – Distribution Channel Segment 2017 - 2021 ($ million)
- 4.3 Type Segment Analysis 2017 - 2021
- Exhibit 20: Historic Market Size – Type Segment 2017 - 2021 ($ million)
- 4.4 Geography Segment Analysis 2017 - 2021
- Exhibit 21: Historic Market Size – Geography Segment 2017 - 2021 ($ million)
- 4.5 Country Segment Analysis 2017 - 2021
- Exhibit 22: Historic Market Size – Country Segment 2017 - 2021 ($ million)
5 Five Forces Analysis
- 5.1 Five forces summary
- Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
- 5.2 Bargaining power of buyers
- Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
- 5.3 Bargaining power of suppliers
- Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
- 5.4 Threat of new entrants
- Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
- 5.5 Threat of substitutes
- Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
- 5.6 Threat of rivalry
- Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
- 5.7 Market condition
- Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
6 Market Segmentation by Distribution Channel
- 6.1 Market segments
- Exhibit 30: Chart on Distribution Channel - Market share 2022-2027 (%)
- Exhibit 31: Data Table on Distribution Channel - Market share 2022-2027 (%)
- 6.2 Comparison by Distribution Channel
- Exhibit 32: Chart on Comparison by Distribution Channel
- Exhibit 33: Data Table on Comparison by Distribution Channel
- 6.3 Offline - Market size and forecast 2022-2027
- Exhibit 34: Chart on Offline - Market size and forecast 2022-2027 ($ million)
- Exhibit 35: Data Table on Offline - Market size and forecast 2022-2027 ($ million)
- Exhibit 36: Chart on Offline - Year-over-year growth 2022-2027 (%)
- Exhibit 37: Data Table on Offline - Year-over-year growth 2022-2027 (%)
- 6.4 Online - Market size and forecast 2022-2027
- Exhibit 38: Chart on Online - Market size and forecast 2022-2027 ($ million)
- Exhibit 39: Data Table on Online - Market size and forecast 2022-2027 ($ million)
- Exhibit 40: Chart on Online - Year-over-year growth 2022-2027 (%)
- Exhibit 41: Data Table on Online - Year-over-year growth 2022-2027 (%)
- 6.5 Market opportunity by Distribution Channel
- Exhibit 42: Market opportunity by Distribution Channel ($ million)
- Exhibit 43: Data Table on Market opportunity by Distribution Channel ($ million)
7 Market Segmentation by Type
- 7.1 Market segments
- Exhibit 44: Chart on Type - Market share 2022-2027 (%)
- Exhibit 45: Data Table on Type - Market share 2022-2027 (%)
- 7.2 Comparison by Type
- Exhibit 46: Chart on Comparison by Type
- Exhibit 47: Data Table on Comparison by Type
- 7.3 Antidepressants - Market size and forecast 2022-2027
- Exhibit 48: Chart on Antidepressants - Market size and forecast 2022-2027 ($ million)
- Exhibit 49: Data Table on Antidepressants - Market size and forecast 2022-2027 ($ million)
- Exhibit 50: Chart on Antidepressants - Year-over-year growth 2022-2027 (%)
- Exhibit 51: Data Table on Antidepressants - Year-over-year growth 2022-2027 (%)
- 7.4 Anticonvulsants - Market size and forecast 2022-2027
- Exhibit 52: Chart on Anticonvulsants - Market size and forecast 2022-2027 ($ million)
- Exhibit 53: Data Table on Anticonvulsants - Market size and forecast 2022-2027 ($ million)
- Exhibit 54: Chart on Anticonvulsants - Year-over-year growth 2022-2027 (%)
- Exhibit 55: Data Table on Anticonvulsants - Year-over-year growth 2022-2027 (%)
- 7.5 Stimulants and others - Market size and forecast 2022-2027
- Exhibit 56: Chart on Stimulants and others - Market size and forecast 2022-2027 ($ million)
- Exhibit 57: Data Table on Stimulants and others - Market size and forecast 2022-2027 ($ million)
- Exhibit 58: Chart on Stimulants and others - Year-over-year growth 2022-2027 (%)
- Exhibit 59: Data Table on Stimulants and others - Year-over-year growth 2022-2027 (%)
- 7.6 Market opportunity by Type
- Exhibit 60: Market opportunity by Type ($ million)
- Exhibit 61: Data Table on Market opportunity by Type ($ million)
8 Customer Landscape
- 8.1 Customer landscape overview
- Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
- 9.1 Geographic segmentation
- Exhibit 63: Chart on Market share by geography 2022-2027 (%)
- Exhibit 64: Data Table on Market share by geography 2022-2027 (%)
- 9.2 Geographic comparison
- Exhibit 65: Chart on Geographic comparison
- Exhibit 66: Data Table on Geographic comparison
- 9.3 North America - Market size and forecast 2022-2027
- Exhibit 67: Chart on North America - Market size and forecast 2022-2027 ($ million)
- Exhibit 68: Data Table on North America - Market size and forecast 2022-2027 ($ million)
- Exhibit 69: Chart on North America - Year-over-year growth 2022-2027 (%)
- Exhibit 70: Data Table on North America - Year-over-year growth 2022-2027 (%)
- 9.4 Europe - Market size and forecast 2022-2027
- Exhibit 71: Chart on Europe - Market size and forecast 2022-2027 ($ million)
- Exhibit 72: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
- Exhibit 73: Chart on Europe - Year-over-year growth 2022-2027 (%)
- Exhibit 74: Data Table on Europe - Year-over-year growth 2022-2027 (%)
- 9.5 Asia - Market size and forecast 2022-2027
- Exhibit 75: Chart on Asia - Market size and forecast 2022-2027 ($ million)
- Exhibit 76: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
- Exhibit 77: Chart on Asia - Year-over-year growth 2022-2027 (%)
- Exhibit 78: Data Table on Asia - Year-over-year growth 2022-2027 (%)
- 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
- Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
- Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
- Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
- Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
- 9.7 US - Market size and forecast 2022-2027
- Exhibit 83: Chart on US - Market size and forecast 2022-2027 ($ million)
- Exhibit 84: Data Table on US - Market size and forecast 2022-2027 ($ million)
- Exhibit 85: Chart on US - Year-over-year growth 2022-2027 (%)
- Exhibit 86: Data Table on US - Year-over-year growth 2022-2027 (%)
- 9.8 UK - Market size and forecast 2022-2027
- Exhibit 87: Chart on UK - Market size and forecast 2022-2027 ($ million)
- Exhibit 88: Data Table on UK - Market size and forecast 2022-2027 ($ million)
- Exhibit 89: Chart on UK - Year-over-year growth 2022-2027 (%)
- Exhibit 90: Data Table on UK - Year-over-year growth 2022-2027 (%)
- 9.9 Germany - Market size and forecast 2022-2027
- Exhibit 91: Chart on Germany - Market size and forecast 2022-2027 ($ million)
- Exhibit 92: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
- Exhibit 93: Chart on Germany - Year-over-year growth 2022-2027 (%)
- Exhibit 94: Data Table on Germany - Year-over-year growth 2022-2027 (%)
- 9.10 China - Market size and forecast 2022-2027
- Exhibit 95: Chart on China - Market size and forecast 2022-2027 ($ million)
- Exhibit 96: Data Table on China - Market size and forecast 2022-2027 ($ million)
- Exhibit 97: Chart on China - Year-over-year growth 2022-2027 (%)
- Exhibit 98: Data Table on China - Year-over-year growth 2022-2027 (%)
- 9.11 India - Market size and forecast 2022-2027
- Exhibit 99: Chart on India - Market size and forecast 2022-2027 ($ million)
- Exhibit 100: Data Table on India - Market size and forecast 2022-2027 ($ million)
- Exhibit 101: Chart on India - Year-over-year growth 2022-2027 (%)
- Exhibit 102: Data Table on India - Year-over-year growth 2022-2027 (%)
- 9.12 Market opportunity by geography
- Exhibit 103: Market opportunity by geography ($ million)
- Exhibit 104: Data Tables on Market opportunity by geography ($ million)
10 Drivers, Challenges, and Trends
- 10.1 Market drivers
- 10.2 Market challenges
- 10.3 Impact of drivers and challenges
- Exhibit 105: Impact of drivers and challenges in 2022 and 2027
- 10.4 Market trends
11 Vendor Landscape
- 11.1 Overview
- 11.2 Vendor landscape
- Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
- 11.3 Landscape disruption
- Exhibit 107: Overview on factors of disruption
- 11.4 Industry risks
- Exhibit 108: Impact of key risks on business
12 Vendor Analysis
- 12.1 Vendors covered
- Exhibit 109: Vendors covered
- 12.2 Market positioning of vendors
- Exhibit 110: Matrix on vendor position and classification
- 12.3 Alvogen Iceland ehf
- Exhibit 111: Alvogen Iceland ehf - Overview
- Exhibit 112: Alvogen Iceland ehf - Product / Service
- Exhibit 113: Alvogen Iceland ehf - Key offerings
- 12.4 Bausch Health Co. Inc.
- Exhibit 114: Bausch Health Co. Inc. - Overview
- Exhibit 115: Bausch Health Co. Inc. - Business segments
- Exhibit 116: Bausch Health Co. Inc. - Key news
- Exhibit 117: Bausch Health Co. Inc. - Key offerings
- Exhibit 118: Bausch Health Co. Inc. - Segment focus
- 12.5 Chronos Therapeutics Ltd.
- Exhibit 119: Chronos Therapeutics Ltd. - Overview
- Exhibit 120: Chronos Therapeutics Ltd. - Product / Service
- Exhibit 121: Chronos Therapeutics Ltd. - Key offerings
- 12.6 Currax Pharmaceuticals LLC
- Exhibit 122: Currax Pharmaceuticals LLC - Overview
- Exhibit 123: Currax Pharmaceuticals LLC - Product / Service
- Exhibit 124: Currax Pharmaceuticals LLC - Key offerings
- 12.7 Eli Lilly and Co.
- Exhibit 125: Eli Lilly and Co. - Overview
- Exhibit 126: Eli Lilly and Co. - Product / Service
- Exhibit 127: Eli Lilly and Co. - Key news
- Exhibit 128: Eli Lilly and Co. - Key offerings
- 12.8 Johnson and Johnson Services Inc.
- Exhibit 129: Johnson and Johnson Services Inc. - Overview
- Exhibit 130: Johnson and Johnson Services Inc. - Business segments
- Exhibit 131: Johnson and Johnson Services Inc. - Key news
- Exhibit 132: Johnson and Johnson Services Inc. - Key offerings
- Exhibit 133: Johnson and Johnson Services Inc. - Segment focus
- 12.9 Lupin Ltd.
- Exhibit 134: Lupin Ltd. - Overview
- Exhibit 135: Lupin Ltd. - Product / Service
- Exhibit 136: Lupin Ltd. - Key news
- Exhibit 137: Lupin Ltd. - Key offerings
- 12.10 Omeros Corp.
- Exhibit 138: Omeros Corp. - Overview
- Exhibit 139: Omeros Corp. - Product / Service
- Exhibit 140: Omeros Corp. - Key offerings
- 12.11 Pyramid Healthcare Inc.
- Exhibit 141: Pyramid Healthcare Inc. - Overview
- Exhibit 142: Pyramid Healthcare Inc. - Product / Service
- Exhibit 143: Pyramid Healthcare Inc. - Key offerings
- 12.12 Sumitomo Pharma Co. Ltd.
- Exhibit 144: Sumitomo Pharma Co. Ltd. - Overview
- Exhibit 145: Sumitomo Pharma Co. Ltd. - Business segments
- Exhibit 146: Sumitomo Pharma Co. Ltd. - Key offerings
- Exhibit 147: Sumitomo Pharma Co. Ltd. - Segment focus
- 12.13 Takeda Pharmaceutical Co. Ltd.
- Exhibit 148: Takeda Pharmaceutical Co. Ltd. - Overview
- Exhibit 149: Takeda Pharmaceutical Co. Ltd. - Product / Service
- Exhibit 150: Takeda Pharmaceutical Co. Ltd. - Key news
- Exhibit 151: Takeda Pharmaceutical Co. Ltd. - Key offerings
- 12.14 Tonix Pharmaceuticals Holding Corp.
- Exhibit 152: Tonix Pharmaceuticals Holding Corp. - Overview
- Exhibit 153: Tonix Pharmaceuticals Holding Corp. - Product / Service
- Exhibit 154: Tonix Pharmaceuticals Holding Corp. - Key offerings
- 12.15 Tryp Therapeutics Inc.
- Exhibit 155: Tryp Therapeutics Inc. - Overview
- Exhibit 156: Tryp Therapeutics Inc. - Product / Service
- Exhibit 157: Tryp Therapeutics Inc. - Key offerings
- 12.16 Viatris Inc.
- Exhibit 158: Viatris Inc. - Overview
- Exhibit 159: Viatris Inc. - Business segments
- Exhibit 160: Viatris Inc. - Key news
- Exhibit 161: Viatris Inc. - Key offerings
- Exhibit 162: Viatris Inc. - Segment focus
- 12.17 VIVUS LLC
- Exhibit 163: VIVUS LLC - Overview
- Exhibit 164: VIVUS LLC - Product / Service
- Exhibit 165: VIVUS LLC - Key offerings
13 Appendix
- 13.1 Scope of the report
- 13.2 Inclusions and exclusions checklist
- Exhibit 166: Inclusions checklist
- Exhibit 167: Exclusions checklist
- 13.3 Currency conversion rates for US$
- Exhibit 168: Currency conversion rates for US$
- 13.4 Research methodology
- Exhibit 169: Research methodology
- Exhibit 170: Validation techniques employed for market sizing
- Exhibit 171: Information sources
- 13.5 List of abbreviations
- Exhibit 172: List of abbreviations
Research Framework
Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
INFORMATION SOURCES
Primary sources
- Manufacturers and suppliers
- Channel partners
- Industry experts
- Strategic decision makers
Secondary sources
- Industry journals and periodicals
- Government data
- Financial reports of key industry players
- Historical data
- Press releases
DATA ANALYSIS
Data Synthesis
- Collation of data
- Estimation of key figures
- Analysis of derived insights
Data Validation
- Triangulation with data models
- Reference against proprietary databases
- Corroboration with industry experts
REPORT WRITING
Qualitative
- Market drivers
- Market challenges
- Market trends
- Five forces analysis
Quantitative
- Market size and forecast
- Market segmentation
- Geographical insights
- Competitive landscape
PURCHASE FULL REPORT OF
binge-eating disorder treatment market
Key Questions Answered
- What are the key global market and the regional market share?
- What are the revenue-generating key market segments?
- What are the key factors driving and challenging this market’s growth?
- Who are the key market vendors and their growth strategies?
- What are the latest trends influencing the growth of this market?
- What are the variables influencing the market growth in the primary regions?
- What are the factors influencing the growth of the parent market?
Why should you prefer Technavio's market insights report?
- Off-the-shelf research reports
- Reports can be tailored to meet the customer's needs
- Trusted by more than 100 fortune 500 organizations
- Information about the market's key drivers, trends, and challenges
- Parent market analysis
- Every week, 50,000 people visit our subscription platform
- Detailed vendors report with competitive landscape
- Covid-19 impact and recovery analysis
- Data on revenue-generating market segments
- Details on the market shares of various regions
- Five-force market analysis